All tau isoforms carrying PTMs at aforementioned positions are eligible for conversion, since these modifications decorate the surface of AD-associated fibrils in the absence of spatial or electrostatic interference (Figure 2). The gene discussed is MAPT; the disease is Alzheimer disease.